ArticleHemaSphere2021

Safety and Efficacy: Clinical Experience of Venetoclax in Combination With Hypomethylating Agents in Both Newly Diagnosed and Relapsed/Refractory Advanced Myeloid Malignancies.

Jonathan Feld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.